LATANOPROST Side Effects

7017028-8 | Eye Infection, Pruritus
on Sep 21, 2010 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: eye infection (What is eye infection?), pruritus. Latanoprost dosage: Unk. During the same period patient was treated with XALATAN (Unk) (View Xalatan Review and Xalatan Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), COLCHICINE (Unk) (View Colchicine Review and Colchicine Label ), FEXOFENADINE (Unk) (View Fexofenadine Review and Fexofenadine Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ).

7008502-9 | Eye Infection, Pruritus
Patient was taking Latanoprost (View Usage). Patient had the following side effects: eye infection (What is eye infection?), pruritus on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 200.0 lb, was diagnosed with glaucoma (What is glaucoma?) and. Latanoprost dosage: Unk. During the same period patient was treated with XALATAN (Unk) (View Xalatan Review and Xalatan Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), COLCHICINE (Unk) (View Colchicine Review and Colchicine Label ), FEXOFENADINE (Unk) (View Fexofenadine Review and Fexofenadine Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ).

6790627-4 | Keratitis Herpetic
Adverse event was reported on May 25, 2010 by a Male patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: PUERTO RICO , 72 years of age, After Latanoprost was administered, patient had the following side effects: keratitis herpetic. During the same period patient was treated with TRAVOPROST (View Travoprost Review and Travoprost Label ).

6690754-6 | Dysphagia, Glossodynia
on Apr 09, 2010 Female patient from UNITED KINGDOM , 69 years of age, weighting 129.0 lb, was diagnosed with hypertension and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, glossodynia. Latanoprost dosage: Unk. During the same period patient was treated with ADIZEM XL (Unk) (View Adizem-xl Review and Adizem-xl Label ).


6616776-9 | Asthenia, Cerebrovascular Accident
on Feb 26, 2010 Female patient from GERMANY , 79 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient had the following side effects: asthenia, cerebrovascular accident. Latanoprost dosage: 0.005 %, 1x/day Both Eyes. During the same period patient was treated with COSOPT (1x/day Both Eyes) (View Cosopt Review and Cosopt Label ).

6555198-6 | Cough
Patient was taking Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: cough on Nov 26, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Latanoprost dosage: . During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CO AMILOFRUSE (View Co-amilofruse Review and Co-amilofruse Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ).

6552536-5 | Cerebrovascular Accident
Adverse event was reported on Jan 19, 2010 by a Female patient taking Latanoprost (View Usage) (Dosage: 0.005 %, 1x/day Both Eyes) was diagnosed with glaucoma (What is glaucoma?) and. Location: GERMANY , 83 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. During the same period patient was treated with COSOPT (1x/day Both Eyes) (View Cosopt Review and Cosopt Label ).

6540221-5 | Anosmia, Macular Oedema, Maculopathy
on Jan 06, 2010 Female patient from GERMANY , 74 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient had the following side effects: anosmia, macular oedema, maculopathy. Latanoprost dosage: 0.005 %, 1x/day. During the same period patient was treated with TIMOLOL (0.5 %, 2x/day) (View Timolol Review and Timolol Label ), BRIMONIDINE (0.2 %, 2x/day) (View Brimonidine Review and Brimonidine Label ).

6447385-2 | Dementia
on Nov 09, 2009 Female patient from GERMANY , 74 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: dementia (What is dementia?). Latanoprost dosage: Unk. Patient was hospitalized.

6425462-X | Intraocular Pressure Increased
Patient was taking Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased on Oct 26, 2009 from RUSSIAN FEDERATION Additional patient health information: Male patient , 60 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Latanoprost dosage: 1 Gtt, 1x/day. During the same period patient was treated with TIMOLOL (Unk, 2x/day) (View Timolol Review and Timolol Label ).

6415800-6 | Dementia
Adverse event was reported on Oct 15, 2009 by a Female patient taking Latanoprost (View Usage) (Dosage: Unk) was diagnosed with glaucoma (What is glaucoma?) and. Location: GERMANY , 74 years of age, Patient had the following side effects: dementia (What is dementia?). Patient was hospitalized.

6285137-7 | Dizziness, Hypotension, Nausea, Syncope
on Jul 15, 2009 Female patient from TURKEY , 46 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: dizziness (What is dizziness?), hypotension, nausea (What is nausea?), syncope. Latanoprost dosage: Unk. During the same period patient was treated with DIDERAL (40 Mg, Unk) (View Dideral Review and Dideral Label ). Patient was hospitalized.

6199485-2 | Eye Burns, Ulcerative Keratitis
on May 11, 2009 Female patient from TURKEY , 57 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: eye burns, ulcerative keratitis. Latanoprost dosage: Unk. During the same period patient was treated with BRIMONIDINE TARTRATE/TIMOLOL MALEATE (View Brimonidine Tartrate/timolol Maleate Review and Brimonidine Tartrate/timolol Maleate Label ).

6182591-6 | Keratitis Herpetic
Patient was taking Latanoprost (View Usage). Patient had the following side effects: keratitis herpetic on May 05, 2009 from PUERTO RICO Additional patient health information: Male patient , 72 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Latanoprost dosage: . During the same period patient was treated with TRAVOPROST (View Travoprost Review and Travoprost Label ).

6175978-9 | Keratitis Herpetic
Adverse event was reported on Apr 21, 2009 by a Male patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: PUERTO RICO , 72 years of age, After Latanoprost was administered, patient had the following side effects: keratitis herpetic. During the same period patient was treated with TRAVOPROST (View Travoprost Review and Travoprost Label ).

6160360-0 | Malignant Melanoma, Metastases To Liver
on Mar 02, 2009 Female patient from FRANCE , 53 years of age, was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: malignant melanoma, metastases to liver. Latanoprost dosage: .

5955569-2 | Adverse Event, Flat Anterior Chamber Of Eye, Hyphaema, Intraocular Lens Implant, Intraocular Pressure Increased, Iridocyclitis, Phacotrabeculectomy, Photocoagulation
on Nov 06, 2008 Male patient from UNITED KINGDOM , 27 years of age, was diagnosed with intraocular pressure increased and was treated with Latanoprost (View Usage). Patient had the following side effects: adverse event, flat anterior chamber of eye, hyphaema, intraocular lens implant, intraocular pressure increased, iridocyclitis, phacotrabeculectomy, photocoagulation. Latanoprost dosage: . During the same period patient was treated with PILOCARPINE HYDROCHLORIDE (View Pilocarpine Hydrochloride Review and Pilocarpine Hydrochloride Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5915886-9 | Cataract, Macular Cyst
Patient was taking Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: cataract (What is cataract?), macular cyst on Oct 01, 2008 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with open angle glaucoma and. Latanoprost dosage: .

5900612-X | Adverse Event, Flat Anterior Chamber Of Eye, Hyphaema, Intraocular Lens Implant, Intraocular Pressure Increased, Iridocyclitis, Phacotrabeculectomy, Photocoagulation, Visual Acuity Reduced
Adverse event was reported on Sep 15, 2008 by a Male patient taking Latanoprost (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 25 years of age, Patient experienced the following unwanted or unexpected effects: adverse event, flat anterior chamber of eye, hyphaema, intraocular lens implant, intraocular pressure increased, iridocyclitis, phacotrabeculectomy, photocoagulation, visual acuity reduced. During the same period patient was treated with PILOCARPINE HYDROCHLORIDE (View Pilocarpine Hydrochloride Review and Pilocarpine Hydrochloride Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5887058-8 | Hyphaema, Intraocular Lens Implant, Intraocular Pressure Increased, Iridocyclitis, Phacotrabeculectomy, Photocoagulation, Visual Acuity Reduced
on Sep 09, 2008 Female patient from UNITED KINGDOM , 25 years of age, was treated with Latanoprost (View Usage). Patient had the following side effects: hyphaema, intraocular lens implant, intraocular pressure increased, iridocyclitis, phacotrabeculectomy, photocoagulation, visual acuity reduced. Latanoprost dosage: . During the same period patient was treated with PILOCARPINE HYDROCHLORIDE (View Pilocarpine Hydrochloride Review and Pilocarpine Hydrochloride Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5854450-7 | Trabeculectomy, Vitrectomy
on Aug 11, 2008 Female patient from UNITED KINGDOM , 29 years of age, was diagnosed with intraocular pressure increased and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: trabeculectomy, vitrectomy. Latanoprost dosage: . During the same period patient was treated with APRACLONIDINE (View Apraclonidine Review and Apraclonidine Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5853366-X | Iris Adhesions, Vitreous Haemorrhage
Patient was taking Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: iris adhesions, vitreous haemorrhage on Aug 11, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 20 years of age, was diagnosed with glaucoma (What is glaucoma?), intraocular pressure increased and. Latanoprost dosage: . During the same period patient was treated with TIMOLOL (View Timolol Review and Timolol Label ), BRIMONIDINE (View Brimonidine Review and Brimonidine Label ), INSULIN (View Insulin Review and Insulin Label ).

5848852-2 | Iris Adhesions, Vitreous Haemorrhage
Adverse event was reported on Aug 06, 2008 by a Female patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), intraocular pressure increased and. Location: UNITED KINGDOM , 20 years of age, Patient had the following side effects: iris adhesions, vitreous haemorrhage. During the same period patient was treated with TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), BRIMONIDINE (View Brimonidine Review and Brimonidine Label ), INSULIN (View Insulin Review and Insulin Label ).

5846275-3 | No Adverse Event
on Jul 24, 2008 Female patient from UNITED KINGDOM , 20 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: no adverse event. Latanoprost dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), INSULIN (View Insulin Review and Insulin Label ).

5834509-0 | Iris Adhesions, Vitreous Haemorrhage
on Jul 24, 2008 Female patient from UNITED KINGDOM , 20 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: iris adhesions, vitreous haemorrhage. Latanoprost dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), INSULIN (View Insulin Review and Insulin Label ).

5826286-4 | No Adverse Event
Patient was taking Latanoprost (View Usage). Patient had the following side effects: no adverse event on Jul 14, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 75 years of age, was diagnosed with normal tension glaucoma and. Latanoprost dosage: .

5825901-9 | Iris Cyst
Adverse event was reported on Jul 14, 2008 by a Female patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with normal tension glaucoma and. Location: UNITED KINGDOM , 75 years of age, After Latanoprost was administered, patient had the following side effects: iris cyst. During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5818337-8 | Fatigue, Heart Rate Increased, Joint Swelling
on Jul 11, 2008 Female patient from UNITED KINGDOM , 69 years of age, weighting 176.4 lb, was diagnosed with intraocular pressure increased and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, heart rate increased, joint swelling. Latanoprost dosage: . During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CORACTEN (View Coracten Review and Coracten Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5818195-1 | Iris Cyst
on Jul 14, 2008 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with normal tension glaucoma and was treated with Latanoprost (View Usage). Patient had the following side effects: iris cyst. Latanoprost dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5799346-4 | Iris Adhesions, Vitreous Haemorrhage
Patient was taking Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: iris adhesions, vitreous haemorrhage on Jun 23, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 20 years of age, was diagnosed with intraocular pressure increased and. Latanoprost dosage: . During the same period patient was treated with TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ).

5792586-X | Trabeculectomy, Vitrectomy
Adverse event was reported on Jun 16, 2008 by a Female patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased and. Location: UNITED KINGDOM , 29 years of age, Patient experienced the following unwanted or unexpected effects: trabeculectomy, vitrectomy. During the same period patient was treated with APRACLONIDINE (View Apraclonidine Review and Apraclonidine Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5728061-8 | Iris Cyst
on Apr 23, 2008 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with normal tension glaucoma and was treated with Latanoprost (View Usage). Patient had the following side effects: iris cyst. Latanoprost dosage: .

5620740-6 | Intraocular Pressure Increased
on Feb 04, 2008 Female patient from RUSSIAN FEDERATION , 71 years of age, was diagnosed with open angle glaucoma and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: intraocular pressure increased. Latanoprost dosage: .

5613019-X | Conjunctival Oedema, Conjunctivitis Allergic, Eyelid Oedema, Pruritus
Patient was taking Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival oedema, conjunctivitis allergic, eyelid oedema, pruritus on Jan 24, 2008 from ROMANIA Additional patient health information: Female patient , 81 years of age, was diagnosed with intraocular pressure increased and. Latanoprost dosage: . Patient was hospitalized.

5565336-X | Intraocular Pressure Increased
Adverse event was reported on Dec 06, 2007 by a Female patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: , 79 years of age, Patient had the following side effects: intraocular pressure increased.

5513342-3 | Iris Cyst
on Oct 31, 2007 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: iris cyst. Latanoprost dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5508213-2 | Eye Pain, Hyphaema, Intraocular Pressure Increased
on Oct 25, 2007 Male patient from RUSSIAN FEDERATION , 79 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: eye pain, hyphaema, intraocular pressure increased. Latanoprost dosage: . During the same period patient was treated with TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

5502501-1 | Iris Cyst
Patient was taking Latanoprost (View Usage). Patient had the following side effects: iris cyst on Oct 17, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 75 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Latanoprost dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5418748-9 | Corneal Deposits
Adverse event was reported on Aug 08, 2007 by a Female patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), ulcerative keratitis and. Location: UNITED KINGDOM , 82 years of age, After Latanoprost was administered, patient had the following side effects: corneal deposits. During the same period patient was treated with CYCLOPENTOLATE HYDROCHLORIDE (View Cyclopentolate Hydrochloride Review and Cyclopentolate Hydrochloride Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ).

5403267-6 | Corneal Deposits
on Jul 20, 2007 Female patient from UNITED KINGDOM , 82 years of age, was diagnosed with glaucoma (What is glaucoma?), ulcerative keratitis and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: corneal deposits. Latanoprost dosage: . During the same period patient was treated with CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ).

5401797-4 | Corneal Deposits
on Jul 19, 2007 Female patient from UNITED KINGDOM , 82 years of age, was diagnosed with glaucoma (What is glaucoma?), ulcerative keratitis and was treated with Latanoprost (View Usage). Patient had the following side effects: corneal deposits. Latanoprost dosage: . During the same period patient was treated with CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ).

5344551-4 | Ectropion, Surgery
Patient was taking Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: ectropion, surgery (What is surgery?) on May 23, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 89 years of age, was diagnosed with open angle glaucoma and. Latanoprost dosage: . During the same period patient was treated with DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ).

5344550-2 | Ectropion, Entropion, Eyelid Operation, Trabeculectomy
Adverse event was reported on May 23, 2007 by a Male patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with open angle glaucoma and. Location: UNITED KINGDOM , 76 years of age, Patient experienced the following unwanted or unexpected effects: ectropion, entropion, eyelid operation, trabeculectomy. During the same period patient was treated with BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ).

5344549-6 | Ectropion, Surgery
on May 23, 2007 Male patient from UNITED KINGDOM , 90 years of age, was diagnosed with open angle glaucoma and was treated with Latanoprost (View Usage). Patient had the following side effects: ectropion, surgery (What is surgery?). Latanoprost dosage: . During the same period patient was treated with DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ).

5335291-6 | Abnormal Sensation In Eye, Eye Disorder, Eye Irritation, Ocular Hyperaemia
on May 16, 2007 Female patient from BRAZIL , weighting 165.3 lb, was diagnosed with intraocular pressure increased, fungal infection (What is fungal infection?), hypothyroidism, hypertension and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: abnormal sensation in eye, eye disorder, eye irritation, ocular hyperaemia. Latanoprost dosage: . During the same period patient was treated with TERBINAFINE HCL (View Terbinafine Hcl Review and Terbinafine Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIFROL (View Sifrol Review and Sifrol Label ).

5333968-X | Asthma, Cough, Diaphragmatic Injury, Intraocular Pressure Increased, Lung Disorder
Patient was taking Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), cough, diaphragmatic injury, intraocular pressure increased, lung disorder on May 14, 2007 from CANADA Additional patient health information: Female patient , weighting 196.0 lb, was diagnosed with glaucoma (What is glaucoma?), epilepsy (What is epilepsy?), thyroid disorder, cough and. Latanoprost dosage: . During the same period patient was treated with NAPROXEN (View Naproxen Review and Naproxen Label ), ADVIL (View Advil Review and Advil Label ), ASCORBIC ACID (Daily Dose:1000cc) (View Ascorbic Acid Review and Ascorbic Acid Label ), LEVOTHYROXINE SODIUM (Daily Dose:.1mg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEGA (View Omega Review and Omega Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), THYME (View Thyme Review and Thyme Label ).

5317150-8 | Carotid Artery Bypass
Adverse event was reported on Apr 27, 2007 by a Male patient taking Latanoprost (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , weighting 170.0 lb, Patient had the following side effects: carotid artery bypass. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), NORVASC (View Norvasc Review and Norvasc Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), ECOSPRIN (View Ecosprin Review and Ecosprin Label ).

5315115-3 | Anxiety, Discomfort, Extrasystoles, Fear, Lethargy
on Apr 20, 2007 Male patient from UNITED KINGDOM , weighting 154.3 lb, was diagnosed with intraocular pressure increased and was treated with Latanoprost (View Usage). After Latanoprost was administered, patient had the following side effects: anxiety (What is anxiety?), discomfort, extrasystoles, fear, lethargy. Latanoprost dosage: .

5282178-3 | Headache, Hypertension, Tinnitus
on Mar 20, 2007 Male patient from CHILE , 86 years of age, weighting 189.6 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Latanoprost (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), hypertension, tinnitus (What is tinnitus?). Latanoprost dosage: . During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

5255629-8 | Headache, Hypertension, Tinnitus
Patient was taking Latanoprost (View Usage). Patient had the following side effects: headache (What is headache?), hypertension, tinnitus (What is tinnitus?) on Feb 20, 2007 from CHILE Additional patient health information: Male patient , 86 years of age, weighting 189.6 lb, was diagnosed with glaucoma (What is glaucoma?) and. Latanoprost dosage: . During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).